Company · CIK 0001235010 · SIC 2836 — Biological Products, (No Diagnostic Substances)
MOMENTA PHARMACEUTICALS INC · MNTA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2015 MForm 4 → | Jun 19, 4:04 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | $7.41 | $185,250 | 130,902 | — | plan? |
| Jun 17, 2015 SForm 4 → | Jun 19, 4:00 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 36,313 | $23.58 | $856,099 | 99,380 | −26.8% | plan? |
| Jun 17, 2015 MForm 4 → | Jun 19, 4:00 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 25,313 | $12.84 | $324,940 | 119,943 | — | plan? |
| Jun 11, 2015 SForm 4 → | Jun 15, 11:14 am EDT | Michael FrankenPresident, Biosimilars Busines | 512 | $22.37 | $11,453 | 39,001 | −1.30% | plan? |
| Jun 4, 2015 SForm 4 → | Jun 5, 1:53 pm EDT | Craig A WheelerPresident, Director | 103,333 | $22.00 | $2,273,326 | 211,032 | −32.9% | plan? |
| Jun 4, 2015 MForm 4 → | Jun 5, 1:53 pm EDT | Craig A WheelerPresident, Director | 83,333 | $16.18 | $1,348,328 | 301,645 | — | plan? |
| Jun 1, 2015 SForm 4 → | Jun 2, 3:54 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | $21.00 | $840,000 | 117,817 | −25.3% | plan? |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:54 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | $15.12 | $604,800 | 127,817 | — | plan? |
| Jun 1, 2015 SForm 4 → | Jun 2, 3:46 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | $21.70 | $542,500 | 105,902 | −19.1% | plan? |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:46 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | $7.41 | $185,250 | 130,902 | — | plan? |
| May 26, 2015 SForm 4 → | May 27, 11:53 am EDT | John E BishopSenior VP, Pharmaceutical Scie | 254 | $19.80 | $5,029 | 110,380 | −0.23% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:14 pm EDT | Craig A WheelerPresident, Director | 1,766 | $19.68 | $34,755 | 224,594 | −0.78% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:13 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 227 | $19.68 | $4,467 | 110,634 | −0.20% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:11 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 227 | $19.68 | $4,467 | 388,785 | −0.06% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:08 pm EDT | Richard P SheaSVP, CFO | 227 | $19.68 | $4,467 | 144,048 | −0.16% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:06 pm EDT | Bruce LeicherSVP & General Counsel | 227 | $19.68 | $4,467 | 117,817 | −0.19% | plan? |
| May 20, 2015 SForm 4 → | May 21, 4:03 pm EDT | James M. RoachSenior VP, Development and Chi | 360 | $19.68 | $7,085 | 105,902 | −0.34% | plan? |
| May 19, 2015 SForm 4 → | May 20, 3:26 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 406 | $19.63 | $7,970 | 389,012 | −0.10% | plan? |
| May 19, 2015 SForm 4 → | May 20, 3:20 pm EDT | James M. RoachSenior VP, Development and Chi | 617 | $19.63 | $12,112 | 106,262 | −0.58% | plan? |
| May 19, 2015 SForm 4 → | May 20, 3:13 pm EDT | Richard P SheaSVP, CFO | 406 | $19.63 | $7,970 | 144,275 | −0.28% | plan? |
| May 19, 2015 SForm 4 → | May 20, 3:10 pm EDT | Craig A WheelerPresident, Director | 2,061 | $19.67 | $40,540 | 226,360 | −0.90% | plan? |
| May 19, 2015 SForm 4 → | May 20, 3:05 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 624 | $19.63 | $12,249 | 110,861 | −0.56% | plan? |
| May 19, 2015 SForm 4 → | May 20, 12:58 pm EDT | Bruce LeicherSVP & General Counsel | 426 | $19.63 | $8,362 | 118,044 | −0.36% | plan? |
| May 15, 2015 SForm 4 → | May 19, 4:58 pm EDT | Craig A WheelerPresident, Director | 1,766 | $19.92 | $35,179 | 228,421 | −0.77% | plan? |
| May 15, 2015 SForm 4 → | May 19, 2:44 pm EDT | Richard P SheaSVP, CFO | 145 | $19.96 | $2,894 | 144,681 | −0.10% | plan? |
| May 15, 2015 SForm 4 → | May 19, 2:40 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 215 | $19.96 | $4,291 | 389,418 | −0.06% | plan? |
| May 15, 2015 SForm 4 → | May 19, 2:38 pm EDT | James M. RoachSenior VP, Development and Chi | 311 | $19.96 | $6,208 | 106,879 | −0.29% | plan? |
| May 15, 2015 SForm 4 → | May 19, 1:23 pm EDT | Bruce LeicherSVP & General Counsel | 267 | $19.96 | $5,329 | 118,470 | −0.22% | plan? |
| May 12, 2015 SForm 4 → | May 14, 3:17 pm EDT | John K ClarkeDirector | 38,400 | $19.96 | $766,464 | 69,123 | −35.7% | plan? |
| May 12, 2015 MForm 4 → | May 14, 3:17 pm EDT | John K ClarkeDirector | 38,400 | $10.44 | $400,896 | 107,523 | — | plan? |
| May 11, 2015 SForm 4 → | May 13, 2:33 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 33,625 | $20.70 | $696,038 | 111,485 | −23.2% | plan? |
| May 11, 2015 MForm 4 → | May 13, 2:33 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 33,625 | $15.72 | $528,591 | 137,610 | — | plan? |
| May 6, 2015 SForm 4 → | May 8, 1:34 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 493 | $19.05 | $9,392 | 111,485 | −0.44% | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 2:05 pm EDT | Craig A WheelerPresident, Director | 51,667 | $20.00 | $1,033,340 | 196,308 | −20.8% | plan? |
| Apr 23, 2015 MForm 4 → | Apr 27, 2:05 pm EDT | Craig A WheelerPresident, Director | 41,667 | $16.18 | $674,172 | 300,296 | — | plan? |
| Apr 23, 2015 SForm 4 → | Apr 27, 1:58 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 34,000 | $19.95 | $678,300 | 389,633 | −8.03% | plan? |
| Apr 20, 2015 SForm 4 → | Apr 22, 1:17 pm EDT | Craig A WheelerPresident, Director | 6,269 | $18.75 | $117,544 | 258,629 | −2.37% | plan? |
| Apr 16, 2015 SForm 4 → | Apr 20, 4:26 pm EDT | James M. RoachSenior VP, Development and Chi | 50,000 | $18.70 | $935,000 | 107,190 | −31.8% | plan? |
| Apr 16, 2015 SForm 4 → | Apr 20, 4:06 pm EDT | Bruce LeicherSVP & General Counsel | 52,910 | $19.52 | $1,033,026 | 118,737 | −30.8% | plan? |
| Mar 29, 2015 DFForm 4 → | Apr 20, 4:33 pm EDT | Craig A WheelerPresident, Director | 50,102 | $17.08 | $477,847 | 264,898 | — | plan? late |
| Mar 29, 2015 DFForm 4 → | Apr 20, 4:28 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 12,965 | $17.08 | $106,152 | 111,978 | — | plan? late |
| Mar 29, 2015 DFMForm 4 → | Apr 20, 4:26 pm EDT | James M. RoachSenior VP, Development and Chi | 62,965 | $8.48 | $476,652 | 157,190 | — | plan? late |
| Mar 29, 2015 DFForm 4 → | Apr 20, 4:23 pm EDT | Ganesh Venkataraman KaundinyaSenior V.P., Research | 12,965 | $17.08 | $106,152 | 423,633 | — | plan? late |
| Mar 29, 2015 DFForm 4 → | Apr 20, 4:13 pm EDT | Richard P SheaSVP, CFO | 12,965 | $17.08 | $106,152 | 144,826 | — | plan? late |
| Mar 29, 2015 DFMForm 4 → | Apr 20, 4:06 pm EDT | Bruce LeicherSVP & General Counsel | 52,965 | $15.38 | $710,952 | 171,647 | — | plan? late |
| Mar 16, 2015 SForm 4 → | Mar 17, 1:55 pm EDT | Richard P SheaSVP, CFO | 23,093 | $15.10 | $348,704 | 157,791 | −12.8% | plan? |
| Mar 11, 2015 SForm 4 → | Mar 13, 10:25 am EDT | Michael FrankenPresident, Biosimilars Busines | 512 | $14.71 | $7,532 | 39,513 | −1.28% | plan? |
| Mar 5, 2015 SForm 4 → | Mar 9, 10:29 am EDT | Richard P SheaSVP, CFO | 23,364 | $14.90 | $348,124 | 180,884 | −11.4% | plan? |
| Feb 25, 2015 SForm 4 → | Feb 26, 1:43 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 64 | $13.20 | $845 | 124,943 | −0.05% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 2:56 pm EST | Richard P SheaSVP, CFO | 192 | $13.56 | $2,604 | 204,248 | −0.09% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 2:53 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 211 | $13.56 | $2,861 | 436,598 | −0.05% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 2:46 pm EST | Bruce LeicherSVP & General Counsel | 192 | $13.56 | $2,604 | 144,612 | −0.13% | plan? |
| Feb 24, 2015 SForm 4 → | Feb 25, 2:34 pm EST | Craig A WheelerPresident, Director | 2,110 | $13.52 | $28,527 | 337,769 | −0.62% | plan? |
| Feb 23, 2015 SForm 4 → | Feb 25, 2:59 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 340 | $13.32 | $4,529 | 125,007 | −0.27% | plan? |
| Feb 23, 2015 SForm 4 → | Feb 25, 2:41 pm EST | James M. RoachSenior VP, Development and Chi | 391 | $13.24 | $5,177 | 120,155 | −0.32% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 4:30 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 1,768 | $12.97 | $22,936 | 125,347 | −1.39% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 4:27 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 1,812 | $12.97 | $23,504 | 436,809 | −0.41% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 4:14 pm EST | Craig A WheelerPresident, Director | 9,563 | $13.49 | $129,039 | 339,879 | −2.74% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 4:11 pm EST | Richard P SheaSVP, CFO | 1,812 | $12.97 | $23,504 | 204,440 | −0.88% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 4:03 pm EST | James M. RoachSenior VP, Development and Chi | 1,913 | $12.97 | $24,819 | 120,546 | −1.56% | plan? |
| Feb 19, 2015 SForm 4 → | Feb 23, 2:31 pm EST | Bruce LeicherSVP & General Counsel | 1,891 | $12.97 | $24,524 | 144,804 | −1.29% | plan? |
| Feb 18, 2015 SForm 4 → | Feb 20, 3:04 pm EST | Richard P SheaSVP, CFO | 169 | $11.91 | $2,013 | 206,252 | −0.08% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Richard P SheaSVP, CFO | 16,976 | — | — | 206,421 | — | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Michael FrankenPresident, Biosimilars Busines | 16,976 | — | — | 40,025 | — | plan? |
| Feb 18, 2015 SForm 4 → | Feb 20, 3:03 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 252 | $11.91 | $3,001 | 127,115 | −0.20% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 18,862 | — | — | 127,367 | — | plan? |
| Feb 18, 2015 SForm 4 → | Feb 20, 3:03 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 252 | $11.91 | $3,001 | 438,621 | −0.06% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 20,748 | — | — | 438,873 | — | plan? |
| Feb 18, 2015 SForm 4 → | Feb 20, 3:02 pm EST | James M. RoachSenior VP, Development and Chi | 252 | $11.91 | $3,001 | 122,459 | −0.21% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | James M. RoachSenior VP, Development and Chi | 20,748 | — | — | 122,711 | — | plan? |
| Feb 18, 2015 SForm 4 → | Feb 20, 3:02 pm EST | Craig A WheelerPresident, Director | 1,688 | $11.91 | $20,104 | 349,442 | −0.48% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | Craig A WheelerPresident, Director | 70,000 | — | — | 351,130 | — | plan? |
| Feb 18, 2015 SForm 4 → | Feb 19, 3:42 pm EST | Bruce LeicherSVP & General Counsel | 312 | $11.91 | $3,716 | 146,695 | −0.21% | plan? |
| Feb 18, 2015 AForm 4 → | Feb 19, 3:42 pm EST | Bruce LeicherSVP & General Counsel | 18,862 | — | — | 147,007 | — | plan? |
| Feb 11, 2015 MForm 4 → | Feb 12, 3:41 pm EST | Bruce DowneyDirector | 10,000 | $8.85 | $88,500 | 10,000 | — | plan? |
| Jan 16, 2015 MForm 4 → | Jan 20, 3:53 pm EST | Richard P SheaSVP, CFO | 11,250 | $6.88 | $77,400 | 189,001 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2016 AForm 4 → | Jun 27, 2:27 pm EDT | Bruce DowneyDirector | 11,000 | — | — | 11,000 | — | |
| Jun 22, 2016 AForm 4 → | Jun 24, 3:25 pm EDT | Steven C GilmanDirector | 33,000 | — | — | 33,000 | — | |
| Jun 1, 2016 MForm 4 → | Jun 8, 3:55 pm EDT | Bennett M ShapiroDirector | 5,200 | $12.90 | $67,080 | 14,000 | — | late |
| Mar 9, 2016 AForm 4 → | Mar 11, 1:17 pm EST | Jose-Carlos Gutierrez-RamosDirector | 30,000 | — | — | 30,000 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 4:24 pm EST | Bruce LeicherSVP & General Counsel | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:27 pm EST | Craig A WheelerPresident, Director | 126,000 | — | — | 126,000 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:23 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:13 pm EST | James M. RoachSenior VP, Development and Chi | 34,200 | — | — | 34,200 | — | |
| Feb 9, 2016 AForm 4 → | Feb 11, 2:06 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 37,800 | — | — | 37,800 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 1:35 pm EST | Georges GemayelDirector | 30,000 | — | — | 30,000 | — | |
| Dec 10, 2015 AForm 4 → | Dec 14, 4:57 pm EST | Matthew P. OttmerChief Operating Officer | 175,000 | — | — | 175,000 | — | |
| Nov 5, 2015 MForm 4 → | Nov 6, 3:24 pm EST | Craig A WheelerPresident, Director | 41,667 | — | — | 83,333 | — | |
| Aug 10, 2015 MForm 4 → | Aug 14, 12:43 pm EDT | Michael FrankenPresident, Biosimilars Busines | 20,000 | — | — | 50,000 | — | late |
| Jul 15, 2015 MForm 4 → | Jul 16, 2:58 pm EDT | Elizabeth StonerDirector | 6,667 | — | — | 10,000 | — | |
| Jun 19, 2015 MForm 4 → | Jun 22, 4:24 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 21,274 | — | — | 0 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 4:17 pm EDT | Craig A WheelerPresident, Director | 125,000 | — | — | 125,000 | — | |
| Jun 18, 2015 MForm 4 → | Jun 22, 2:19 pm EDT | Bruce LeicherSVP & General Counsel | 20,000 | — | — | 0 | — | |
| Jun 18, 2015 MForm 4 → | Jun 19, 4:04 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | — | — | 47,500 | — | |
| Jun 17, 2015 MForm 4 → | Jun 19, 4:00 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 25,313 | — | — | 0 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 12:00 pm EDT | James R SulatDirector | 17,750 | — | — | 133,750 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:55 am EDT | John K ClarkeDirector | 17,750 | — | — | 176,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:51 am EDT | Marsha FanucciDirector | 17,750 | — | — | 176,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:48 am EDT | Thomas P KoestlerDirector | 17,750 | — | — | 101,000 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:40 am EDT | Elizabeth StonerDirector | 17,750 | — | — | 139,617 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:16 am EDT | Bennett M ShapiroDirector | 17,750 | — | — | 161,350 | — | |
| Jun 10, 2015 AForm 4 → | Jun 11, 11:11 am EDT | Bruce DowneyDirector | 17,750 | — | — | 123,750 | — | |
| Jun 4, 2015 MForm 4 → | Jun 5, 1:53 pm EDT | Craig A WheelerPresident, Director | 83,333 | — | — | 250,000 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:54 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | — | — | 20,000 | — | |
| Jun 1, 2015 MForm 4 → | Jun 2, 3:46 pm EDT | James M. RoachSenior VP, Development and Chi | 25,000 | — | — | 72,500 | — | |
| May 12, 2015 MForm 4 → | May 14, 3:17 pm EDT | John K ClarkeDirector | 38,400 | — | — | 0 | — | |
| May 11, 2015 MForm 4 → | May 13, 2:33 pm EDT | John E BishopSenior VP, Pharmaceutical Scie | 33,625 | — | — | 0 | — | |
| Apr 23, 2015 MForm 4 → | Apr 27, 2:05 pm EDT | Craig A WheelerPresident, Director | 41,667 | — | — | 333,333 | — | |
| Apr 16, 2015 MForm 4 → | Apr 20, 4:26 pm EDT | James M. RoachSenior VP, Development and Chi | 50,000 | — | — | 97,500 | — | |
| Apr 16, 2015 MForm 4 → | Apr 20, 4:06 pm EDT | Bruce LeicherSVP & General Counsel | 40,000 | — | — | 43,548 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Richard P SheaSVP, CFO | 33,953 | $13.02 | $442,068 | 260,056 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:04 pm EST | Michael FrankenPresident, Biosimilars Busines | 33,953 | $13.02 | $442,068 | 103,953 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | John E BishopSenior VP, Pharmaceutical Scie | 37,725 | $13.02 | $491,180 | 223,671 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:03 pm EST | Ganesh Venkataraman KaundinyaSenior V.P., Research | 41,498 | $13.02 | $540,304 | 253,676 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | James M. RoachSenior VP, Development and Chi | 41,498 | $13.02 | $540,304 | 352,413 | — | |
| Feb 18, 2015 AForm 4 → | Feb 20, 3:02 pm EST | Craig A WheelerPresident, Director | 140,000 | $13.02 | $1,822,800 | 1,332,000 | — | |
| Feb 18, 2015 AForm 4 → | Feb 19, 3:42 pm EST | Bruce LeicherSVP & General Counsel | 37,725 | $13.02 | $491,180 | 283,157 | — | |
| Feb 11, 2015 MForm 4 → | Feb 12, 3:41 pm EST | Bruce DowneyDirector | 10,000 | $8.85 | $88,500 | 106,000 | — | |
| Jan 16, 2015 MForm 4 → | Jan 20, 3:53 pm EST | Richard P SheaSVP, CFO | 11,250 | $6.88 | $77,400 | 226,103 | — |